Tshibangu, Térence http://orcid.org/0000-0003-0128-8352
Cawthorne, Christopher
Serdons, Kim
Pauwels, Elin
Gsell, Willy
Bormans, Guy
Deroose, Christophe M.
Cleeren, Frederik
Funding for this research was provided by:
FWO (G0D8817N, 12R3119N)
Stichting Tegen Kanker (STK 2015-145)
Kom op tegen Kanker
Herculesstichting (AKUL/13/29)
Article History
Received: 27 September 2019
Accepted: 16 December 2019
First Online: 29 January 2020
Ethics approval and consent to participate
: All animal experiments described in this manuscript were approved by the Ethical Committee of KU Leuven (ECD number P200/2014) and were conducted according to the Belgian (Royal Decree of 29 May 2013), Flemish (Decision of the Flemish Government to adapt the Royal Decree of 29 May 2013, 17 February 2017) and European (Directive 2010/63/EU) regulations on the protection of animals used for scientific purposes.
: Not applicable.
: The authors declare that they have no competing interests, Christophe M. Deroose is a consultant for Novartis, Terumo, AAA, Ipsen, Sirtex, Bayer outside the submitted work. G. Bormans has contract research studies with UCB, Janssen, Merck, Eikonizo and Celgene.